TRPC3 and cardiac hypertrophy: Inhibition of TRPC3/6 channels have been reported to attenuate heart failure through suppressing myocardial hypertrophy and interstitial fibrosis (Kiyonaka et al., 2009; Kitajima et al., 2011, 2016; Numaga-Tomita et al., 2016).